secwatch.observer — SEC 8-K summary
======================================

Issuer:     USBC, Inc. (USBC)
CIK:        0001074828
Form:       8-K
Filed at:   2023-11-08T23:59:59+00:00
Accession:  0001654954-23-013894
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Know Labs expands board to 7 with three new directors from IP and diabetes sectors
--------------------------------------------------------------------------------

- John Cronin, Larry Ellingson, and Timothy Londergan appointed as independent directors effective Nov 3, 2023.
- Cronin helped boost Know Labs' patent portfolio from 86 to 246 issued, pending or in-process patents in 12 months.
- Ellingson, former Eli Lilly diabetes head, served on Know Labs' advisory board for 4 years prior.
- Londergan, CEO of Tangibly, was named IAM 300 World's Leading IP Strategist 2023.
- New directors receive annual stock option grants and cash retainer of $10,000–$12,500.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1074828/000165495423013894/0001654954-23-013894-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1074828/000165495423013894/knwn_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-013894

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer